Close Menu

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Friday that it has entered into a new $1.5 billion credit agreement, replacing the existing $1 billion revolving credit agreement.

The new agreement is a five-year senior unsecured revolving facility, Thermo Fisher said in a document filed with the US Securities and Exchange Commission. Thermo Fisher entered into the new agreement on July 25.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.